The forecasted total HIV incidence rate in the U.S. remains stable at 0.1 ratios from 2024 to 2026, with a slight decrease to 0.09 ratios in 2027 and 2028. This indicates a year-on-year decrease of about 10% between 2026 to 2027 and stability beyond. The Compound Annual Growth Rate (CAGR) across the forecast period shows a decrease of approximately 2.23% annually from 2024 to 2028, suggesting a modest but steady decline over these years.
Future trends to watch include advancements in HIV prevention and treatment technologies, public health policy changes, and demographic shifts, which could further influence incidence rates. Monitoring these factors is crucial for accurately forecasting the HIV incidence trajectory in the U.S.
